Ingenuity Systems Chosen to be Sole Pathways Provider for Integromics in Andalusian Core Facility

Redwood City, CA – June 20, 2007 – Ingenuity Systems, the leading provider of information solutions for the exploration, interpretation, and analysis of experimental data for life sciences researchers, today announced that it has been awarded a new, five-year contract with Integromics, one of the foremost life science IT companies in Spain and the service provider to the Genomics, Proteomics and Bioinformatics Core Facility of Andalusia (Málaga, Spain). Ingenuity Systems was selected by Integromics to be its sole pathways analysis provider, enabling the Andalusian Core Facility and all of its academic member organizations to use IPA.

The Andalusian Core Facility provides scientists in public research institutions access to a powerful bioinformatic core infrastructure formed by supercomputing hardware facilities and state-of-the-art software. Integromics provides sophisticated software solutions for data management and data analysis in genomics, proteomics, and drug discovery. From its scientific base, Integromics offers its clients a deep and current understanding of challenges, initiatives, and solutions related to life sciences. Integromics has formed important partnerships in industry and academia to develop technological solutions that enable clients to achieve their goals. Integromics is headquartered at the Business Entrepreneur Facilities for Life Sciences of Granada, Spain.

“Ingenuity Systems was selected because they offer the most comprehensive pathways solution, with the most extensive biological and chemical knowledge. IPA provides a great complementarity with other tools for functional analysis of genomic data like Integromic’s ArrayUnlock©. Additionally, IPA provides a remarkable add-on to our portfolio in secondary analysis as it is integrated with our Spotfire DecisionSite® modules for microarray analysis,” commented Pedro A. de Alarcon, Business Development Director of Integromics.

“We are very pleased to have been selected by Integromics to support such a progressive initiative,” stated Brian Dron, Director of European Operations at Ingenuity Systems. “We have earned the confidence of life science researchers through our commitment to quality, usability, and innovation. We are excited to expand our efforts in Spain by delivering these capabilities to support research groups in genomics, proteomics and drug discovery.”

IPA 5.0 is a software and knowledgebase application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA is deployed in all major pharmaceutical companies and in hundreds of biotechnology companies and academic institutions globally. It supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and
development process, including target identification and validation, identification of biomarkers, predictive toxicology, and pharmacogenomics.

Trials of IPA 5.0 are currently being offered at For more information about IPA 5.0, please email or go to

About Ingenuity Systems®

Ingenuity enables researchers to model, analyze, and understand complex biological and chemical systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for life scientists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies. Ingenuity was founded in 1998 and is headquartered in Redwood City, California, with offices in Germany, Switzerland, France, the United Kingdom, and Japan.

About Integromics, SL®

Integromics provides innovative IT solutions for Life Sciences (Genomics and Proteomics). In the post-genomic era, Integromics offers state-of-the-art products, services and training in two
strategic areas: data management/integration and intelligent data analysis. The company has developed a network of collaborations both in the industry (Applied Biosystems, Spotfire Inc) and academia to supply complete technological solutions that will facilitate our clients the achievement of their goals. Integromics, SL was founded in 2002 and it is based in Granada, Spain, having offices in Madrid (Spain), Philadelphia (USA) and Russe (Bulgaria). For more information: